These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

337 related items for PubMed ID: 16913824

  • 1. Peroxisome proliferator-activated receptor-gamma agonists for management and prevention of vascular disease in patients with and without diabetes mellitus.
    Ríos-Vázquez R, Marzoa-Rivas R, Gil-Ortega I, Kaski JC.
    Am J Cardiovasc Drugs; 2006; 6(4):231-42. PubMed ID: 16913824
    [Abstract] [Full Text] [Related]

  • 2. Peroxisome proliferator-activated receptor gamma agonists: their role as vasoprotective agents in diabetes.
    Blaschke F, Caglayan E, Hsueh WA.
    Endocrinol Metab Clin North Am; 2006 Sep; 35(3):561-74, ix. PubMed ID: 16959586
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Peroxisome proliferator-activated receptor gamma agonist improves arterial stiffness in patients with type 2 diabetes mellitus and coronary artery disease.
    Yu J, Jin N, Wang G, Zhang F, Mao J, Wang X.
    Metabolism; 2007 Oct; 56(10):1396-401. PubMed ID: 17884451
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Metabolic and additional vascular effects of thiazolidinediones.
    Martens FM, Visseren FL, Lemay J, de Koning EJ, Rabelink TJ.
    Drugs; 2002 Oct; 62(10):1463-80. PubMed ID: 12093315
    [Abstract] [Full Text] [Related]

  • 8. Peroxisome proliferator-activated receptor-gamma agonists and diabetes: current evidence and future perspectives.
    Chiarelli F, Di Marzio D.
    Vasc Health Risk Manag; 2008 Oct; 4(2):297-304. PubMed ID: 18561505
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Peroxisome proliferator-activated receptor-gamma-mediated effects in the vasculature.
    Duan SZ, Usher MG, Mortensen RM.
    Circ Res; 2008 Feb 15; 102(3):283-94. PubMed ID: 18276926
    [Abstract] [Full Text] [Related]

  • 13. Effect of PPAR-gamma agonist treatment on markers of endothelial dysfunction in patients with type 2 diabetes mellitus.
    Doležalová R, Haluzík MM, Bošanská L, Lacinová Z, Kasalová Z, Stulc T, Haluzík M.
    Physiol Res; 2007 Feb 15; 56(6):741-748. PubMed ID: 17087601
    [Abstract] [Full Text] [Related]

  • 14. Inflammation in diabetes mellitus: role of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma agonists.
    Libby P, Plutzky J.
    Am J Cardiol; 2007 Feb 19; 99(4A):27B-40B. PubMed ID: 17307056
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications.
    Touyz RM, Schiffrin EL.
    Vascul Pharmacol; 2006 Jul 19; 45(1):19-28. PubMed ID: 16782410
    [Abstract] [Full Text] [Related]

  • 18. Oxidant stress impairs in vivo reendothelialization capacity of endothelial progenitor cells from patients with type 2 diabetes mellitus: restoration by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone.
    Sorrentino SA, Bahlmann FH, Besler C, Müller M, Schulz S, Kirchhoff N, Doerries C, Horváth T, Limbourg A, Limbourg F, Fliser D, Haller H, Drexler H, Landmesser U.
    Circulation; 2007 Jul 10; 116(2):163-73. PubMed ID: 17592079
    [Abstract] [Full Text] [Related]

  • 19. PPARgamma agonists and coronary atherosclerosis.
    Sulistio MS, Zion A, Thukral N, Chilton R.
    Curr Atheroscler Rep; 2008 Apr 10; 10(2):134-41. PubMed ID: 18417068
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.